Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of ATL-962 in Obese Patients
jRCT2080221428Phase 3
- Sponsor
- Takeda
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cetilistat in obesity, sponsored by Takeda.
02
Drugs
cetilistat
03
Conditions
obesity
Beyond the preview
Go deeper on jRCT2080221428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221428.